Adam Susser, an associate in the Washington, D.C. office, focuses his practice on regulatory, compliance and transactional matters in industries overseen by the US Food and Drug Administration (FDA) and other federal health agencies, including the pharmaceutical, medical device, food, dietary supplement, cosmetic and tobacco industries.
Mr. Susser has experience with internal investigations and preparations for FDA inspections, the implementation of Good Manufacturing Practice (GMP) and the Quality System Regulation (QSR), and adverse event and medical device reporting. He has experience advising companies preparing for FDA inspections, responding to FDA Form 483s and Warning Letters, and handling adverse events and medical device reports (MDR). Mr. Susser has experience advising clients on compliance issues, drafting healthcare compliance policies and procedures and developing content for compliance training programs. Mr. Susser’s practice also involves internal investigations involving allegations of off-label promotion and healthcare fraud and abuse.
On the transactional side, Mr. Susser provides regulatory counsel on capital markets transactions as well as mergers and acquisitions. He also has reviewed several types of agreements for healthcare clients, including manufacturing and supply, quality, collaboration and merger agreements.
Prior to joining Latham, Mr. Susser graduated with honors from the University of Chicago Law School where he received the Burton and Adrienne Glazov Academic Merit Scholarship. He has devoted his time to many pro bono and community service projects including the D.C. Bar’s Landlord-Tenant Resource Center.